0:00:01.121,0:00:04.110 So, embryonic stem cells 0:00:04.110,0:00:07.410 are really incredible cells. 0:00:07.410,0:00:10.198 They are our body's own repair kits, 0:00:10.198,0:00:13.162 and they're pluripotent, which means they can morph into 0:00:13.162,0:00:15.594 all of the cells in our bodies. 0:00:15.594,0:00:18.282 Soon, we actually will be able to use stem cells 0:00:18.282,0:00:21.267 to replace cells that are damaged or diseased. 0:00:21.267,0:00:23.698 But that's not what I want to talk to you about, 0:00:23.698,0:00:26.376 because right now there are some really 0:00:26.376,0:00:30.322 extraordinary things that we are doing with stem cells 0:00:30.322,0:00:31.929 that are completely changing 0:00:31.929,0:00:34.828 the way we look and model disease, 0:00:34.828,0:00:37.347 our ability to understand why we get sick, 0:00:37.347,0:00:39.778 and even develop drugs. 0:00:39.778,0:00:44.091 I truly believe that stem cell research is going to allow 0:00:44.091,0:00:48.596 our children to look at Alzheimer's and diabetes 0:00:48.596,0:00:52.987 and other major diseases the way we view polio today, 0:00:52.987,0:00:56.188 which is as a preventable disease. 0:00:56.188,0:00:59.411 So here we have this incredible field, which has 0:00:59.411,0:01:03.798 enormous hope for humanity, 0:01:03.798,0:01:07.318 but much like IVF over 35 years ago, 0:01:07.318,0:01:09.652 until the birth of a healthy baby, Louise, 0:01:09.652,0:01:14.721 this field has been under siege politically and financially. 0:01:14.721,0:01:18.993 Critical research is being challenged instead of supported, 0:01:18.993,0:01:23.353 and we saw that it was really essential to have 0:01:23.353,0:01:26.884 private safe haven laboratories where this work 0:01:26.884,0:01:29.714 could be advanced without interference. 0:01:29.714,0:01:32.245 And so, in 2005, 0:01:32.245,0:01:34.857 we started the New York Stem Cell Foundation Laboratory 0:01:34.857,0:01:38.446 so that we would have a small organization that could 0:01:38.446,0:01:41.758 do this work and support it. 0:01:41.758,0:01:45.143 What we saw very quickly is the world of both medical 0:01:45.143,0:01:48.519 research, but also developing drugs and treatments, 0:01:48.519,0:01:52.232 is dominated by, as you would expect, large organizations, 0:01:52.232,0:01:55.351 but in a new field, sometimes large organizations 0:01:55.351,0:01:57.519 really have trouble getting out of their own way, 0:01:57.519,0:01:59.955 and sometimes they can't ask the right questions, 0:01:59.955,0:02:03.311 and there is an enormous gap that's just gotten larger 0:02:03.311,0:02:06.522 between academic research on the one hand 0:02:06.522,0:02:09.223 and pharmaceutical companies and biotechs 0:02:09.223,0:02:12.489 that are responsible for delivering all of our drugs 0:02:12.489,0:02:14.879 and many of our treatments, and so we knew that 0:02:14.879,0:02:18.825 to really accelerate cures and therapies, we were going 0:02:18.825,0:02:21.632 to have to address this with two things: 0:02:21.632,0:02:24.854 new technologies and also a new research model. 0:02:24.854,0:02:28.613 Because if you don't close that gap, you really are 0:02:28.613,0:02:30.220 exactly where we are today. 0:02:30.220,0:02:31.887 And that's what I want to focus on. 0:02:31.887,0:02:35.437 We've spent the last couple of years pondering this, 0:02:35.437,0:02:37.828 making a list of the different things that we had to do, 0:02:37.828,0:02:40.459 and so we developed a new technology, 0:02:40.459,0:02:41.710 It's software and hardware, 0:02:41.710,0:02:45.213 that actually can generate thousands and thousands of 0:02:45.213,0:02:48.383 genetically diverse stem cell lines to create 0:02:48.383,0:02:52.170 a global array, essentially avatars of ourselves. 0:02:52.170,0:02:55.604 And we did this because we think that it's actually going 0:02:55.604,0:02:59.019 to allow us to realize the potential, the promise, 0:02:59.019,0:03:02.099 of all of the sequencing of the human genome, 0:03:02.099,0:03:04.603 but it's going to allow us, in doing that, 0:03:04.603,0:03:09.611 to actually do clinical trials in a dish with human cells, 0:03:09.611,0:03:13.770 not animal cells, to generate drugs and treatments 0:03:13.770,0:03:17.019 that are much more effective, much safer, 0:03:17.019,0:03:20.275 much faster, and at a much lower cost. 0:03:20.275,0:03:22.659 So let me put that in perspective for you 0:03:22.659,0:03:24.075 and give you some context. 0:03:24.075,0:03:28.907 This is an extremely new field. 0:03:28.907,0:03:31.739 In 1998, human embryonic stem cells 0:03:31.739,0:03:35.251 were first identified, and just nine years later, 0:03:35.251,0:03:39.556 a group of scientists in Japan were able to take skin cells 0:03:39.556,0:03:42.751 and reprogram them with very powerful viruses 0:03:42.751,0:03:46.993 to create a kind of pluripotent stem cell 0:03:46.993,0:03:49.083 called an induced pluripotent stem cell, 0:03:49.083,0:03:52.091 or what we refer to as an IPS cell. 0:03:52.091,0:03:55.289 This was really an extraordinary advance, because 0:03:55.289,0:03:57.833 although these cells are not human embryonic stem cells, 0:03:57.833,0:03:59.627 which still remain the gold standard, 0:03:59.627,0:04:03.097 they are terrific to use for modeling disease 0:04:03.097,0:04:05.827 and potentially for drug discovery. 0:04:05.827,0:04:08.867 So a few months later, in 2008, one of our scientists 0:04:08.867,0:04:12.067 built on that research. He took skin biopsies, 0:04:12.067,0:04:14.095 this time from people who had a disease, 0:04:14.095,0:04:17.009 ALS, or as you call it in the U.K., motor neuron disease. 0:04:17.009,0:04:18.707 He turned them into the IPS cells 0:04:18.707,0:04:21.393 that I've just told you about, and then he turned those 0:04:21.393,0:04:24.097 IPS cells into the motor neurons that actually 0:04:24.097,0:04:25.558 were dying in the disease. 0:04:25.558,0:04:28.577 So basically what he did was to take a healthy cell 0:04:28.577,0:04:30.291 and turn it into a sick cell, 0:04:30.291,0:04:33.849 and he recapitulated the disease over and over again 0:04:33.849,0:04:37.209 in the dish, and this was extraordinary, 0:04:37.209,0:04:39.457 because it was the first time that we had a model 0:04:39.457,0:04:43.645 of a disease from a living patient in living human cells. 0:04:43.645,0:04:46.765 And as he watched the disease unfold, he was able 0:04:46.765,0:04:49.776 to discover that actually the motor neurons were dying 0:04:49.776,0:04:51.903 in the disease in a different way than the field 0:04:51.903,0:04:54.397 had previously thought. There was another kind of cell 0:04:54.397,0:04:56.598 that actually was sending out a toxin 0:04:56.598,0:04:59.109 and contributing to the death of these motor neurons, 0:04:59.109,0:05:00.467 and you simply couldn't see it 0:05:00.467,0:05:02.257 until you had the human model. 0:05:02.257,0:05:04.924 So you could really say that 0:05:04.924,0:05:08.830 researchers trying to understand the cause of disease 0:05:08.830,0:05:12.982 without being able to have human stem cell models 0:05:12.982,0:05:15.742 were much like investigators trying to figure out 0:05:15.742,0:05:18.983 what had gone terribly wrong in a plane crash 0:05:18.983,0:05:22.980 without having a black box, or a flight recorder. 0:05:22.980,0:05:25.582 They could hypothesize about what had gone wrong, 0:05:25.582,0:05:28.694 but they really had no way of knowing what led 0:05:28.694,0:05:30.866 to the terrible events. 0:05:30.866,0:05:35.049 And stem cells really have given us the black box 0:05:35.049,0:05:39.017 for diseases, and it's an unprecedented window. 0:05:39.017,0:05:42.262 It really is extraordinary, because you can recapitulate 0:05:42.262,0:05:45.509 many, many diseases in a dish, you can see 0:05:45.509,0:05:49.045 what begins to go wrong in the cellular conversation 0:05:49.045,0:05:51.469 well before you would ever see 0:05:51.469,0:05:54.005 symptoms appear in a patient. 0:05:54.005,0:05:56.528 And this opens up the ability, 0:05:56.528,0:05:59.342 which hopefully will become something that 0:05:59.342,0:06:01.989 is routine in the near term, 0:06:01.989,0:06:06.135 of using human cells to test for drugs. 0:06:06.135,0:06:11.599 Right now, the way we test for drugs is pretty problematic. 0:06:11.599,0:06:14.917 To bring a successful drug to market, it takes, on average, 0:06:14.917,0:06:17.103 13 years — that's one drug — 0:06:17.103,0:06:20.491 with a sunk cost of 4 billion dollars, 0:06:20.491,0:06:25.358 and only one percent of the drugs that start down that road 0:06:25.358,0:06:27.606 are actually going to get there. 0:06:27.606,0:06:29.731 You can't imagine other businesses 0:06:29.731,0:06:31.180 that you would think of going into 0:06:31.180,0:06:32.935 that have these kind of numbers. 0:06:32.935,0:06:34.737 It's a terrible business model. 0:06:34.737,0:06:38.726 But it is really a worse social model because of 0:06:38.726,0:06:42.054 what's involved and the cost to all of us. 0:06:42.054,0:06:45.806 So the way we develop drugs now 0:06:45.806,0:06:49.006 is by testing promising compounds on -- 0:06:49.006,0:06:50.886 We didn't have disease modeling with human cells, 0:06:50.886,0:06:54.350 so we'd been testing them on cells of mice 0:06:54.350,0:06:58.017 or other creatures or cells that we engineer, 0:06:58.017,0:07:01.078 but they don't have the characteristics of the diseases 0:07:01.078,0:07:03.414 that we're actually trying to cure. 0:07:03.414,0:07:06.460 You know, we're not mice, and you can't go into 0:07:06.460,0:07:08.878 a living person with an illness 0:07:08.878,0:07:11.806 and just pull out a few brain cells or cardiac cells 0:07:11.806,0:07:14.095 and then start fooling around in a lab to test 0:07:14.095,0:07:17.656 for, you know, a promising drug. 0:07:17.656,0:07:21.241 But what you can do with human stem cells, now, 0:07:21.241,0:07:25.578 is actually create avatars, and you can create the cells, 0:07:25.578,0:07:27.545 whether it's the live motor neurons 0:07:27.545,0:07:30.555 or the beating cardiac cells or liver cells 0:07:30.555,0:07:34.664 or other kinds of cells, and you can test for drugs, 0:07:34.664,0:07:37.789 promising compounds, on the actual cells 0:07:37.789,0:07:41.420 that you're trying to affect, and this is now, 0:07:41.420,0:07:44.234 and it's absolutely extraordinary, 0:07:44.234,0:07:47.390 and you're going to know at the beginning, 0:07:47.390,0:07:51.134 the very early stages of doing your assay development 0:07:51.134,0:07:54.523 and your testing, you're not going to have to wait 13 years 0:07:54.523,0:07:57.842 until you've brought a drug to market, only to find out 0:07:57.842,0:08:02.898 that actually it doesn't work, or even worse, harms people. 0:08:02.898,0:08:07.238 But it isn't really enough just to look at 0:08:07.238,0:08:11.020 the cells from a few people or a small group of people, 0:08:11.020,0:08:12.664 because we have to step back. 0:08:12.664,0:08:14.515 We've got to look at the big picture. 0:08:14.515,0:08:17.651 Look around this room. We are all different, 0:08:17.651,0:08:20.391 and a disease that I might have, 0:08:20.391,0:08:23.268 if I had Alzheimer's disease or Parkinson's disease, 0:08:23.268,0:08:27.034 it probably would affect me differently than if 0:08:27.034,0:08:28.675 one of you had that disease, 0:08:28.675,0:08:33.020 and if we both had Parkinson's disease, 0:08:33.020,0:08:35.288 and we took the same medication, 0:08:35.288,0:08:38.035 but we had different genetic makeup, 0:08:38.035,0:08:40.320 we probably would have a different result, 0:08:40.320,0:08:44.051 and it could well be that a drug that worked wonderfully 0:08:44.051,0:08:47.630 for me was actually ineffective for you, 0:08:47.630,0:08:52.322 and similarly, it could be that a drug that is harmful for you 0:08:52.322,0:08:56.624 is safe for me, and, you know, this seems totally obvious, 0:08:56.624,0:08:59.352 but unfortunately it is not the way 0:08:59.352,0:09:02.538 that the pharmaceutical industry has been developing drugs 0:09:02.538,0:09:06.524 because, until now, it hasn't had the tools. 0:09:06.524,0:09:08.816 And so we need to move away 0:09:08.816,0:09:11.770 from this one-size-fits-all model. 0:09:11.770,0:09:14.947 The way we've been developing drugs is essentially 0:09:14.947,0:09:16.326 like going into a shoe store, 0:09:16.326,0:09:18.609 no one asks you what size you are, or 0:09:18.609,0:09:20.819 if you're going dancing or hiking. 0:09:20.819,0:09:23.627 They just say, "Well, you have feet, here are your shoes." 0:09:23.627,0:09:27.227 It doesn't work with shoes, and our bodies are 0:09:27.227,0:09:30.699 many times more complicated than just our feet. 0:09:30.699,0:09:33.240 So we really have to change this. 0:09:33.240,0:09:38.424 There was a very sad example of this in the last decade. 0:09:38.424,0:09:41.072 There's a wonderful drug, and a class of drugs actually, 0:09:41.072,0:09:43.752 but the particular drug was Vioxx, and 0:09:43.752,0:09:48.128 for people who were suffering from severe arthritis pain, 0:09:48.128,0:09:51.520 the drug was an absolute lifesaver, 0:09:51.520,0:09:56.600 but unfortunately, for another subset of those people, 0:09:56.600,0:10:01.369 they suffered pretty severe heart side effects, 0:10:01.369,0:10:04.097 and for a subset of those people, the side effects were 0:10:04.097,0:10:07.994 so severe, the cardiac side effects, that they were fatal. 0:10:07.994,0:10:12.036 But imagine a different scenario, 0:10:12.036,0:10:16.338 where we could have had an array, a genetically diverse array, 0:10:16.338,0:10:19.964 of cardiac cells, and we could have actually tested 0:10:19.964,0:10:25.045 that drug, Vioxx, in petri dishes, and figured out, 0:10:25.045,0:10:28.789 well, okay, people with this genetic type are going to have 0:10:28.789,0:10:33.789 cardiac side effects, people with these genetic subgroups 0:10:33.789,0:10:38.933 or genetic shoes sizes, about 25,000 of them, 0:10:38.933,0:10:41.693 are not going to have any problems. 0:10:41.693,0:10:44.308 The people for whom it was a lifesaver 0:10:44.308,0:10:45.985 could have still taken their medicine. 0:10:45.985,0:10:50.371 The people for whom it was a disaster, or fatal, 0:10:50.371,0:10:52.462 would never have been given it, and 0:10:52.462,0:10:55.045 you can imagine a very different outcome for the company, 0:10:55.045,0:10:57.813 who had to withdraw the drug. 0:10:57.813,0:11:00.629 So that is terrific, 0:11:00.629,0:11:02.463 and we thought, all right, 0:11:02.463,0:11:05.222 as we're trying to solve this problem, 0:11:05.222,0:11:07.419 clearly we have to think about genetics, 0:11:07.419,0:11:10.253 we have to think about human testing, 0:11:10.253,0:11:11.832 but there's a fundamental problem, 0:11:11.832,0:11:14.531 because right now, stem cell lines, 0:11:14.531,0:11:16.241 as extraordinary as they are, 0:11:16.241,0:11:17.985 and lines are just groups of cells, 0:11:17.985,0:11:22.317 they are made by hand, one at a time, 0:11:22.317,0:11:24.541 and it takes a couple of months. 0:11:24.541,0:11:28.907 This is not scalable, and also when you do things by hand, 0:11:28.907,0:11:30.450 even in the best laboratories, 0:11:30.450,0:11:33.611 you have variations in techniques, 0:11:33.611,0:11:36.792 and you need to know, if you're making a drug, 0:11:36.792,0:11:38.690 that the Aspirin you're going to take out of the bottle 0:11:38.690,0:11:41.130 on Monday is the same as the Aspirin 0:11:41.130,0:11:43.211 that's going to come out of the bottle on Wednesday. 0:11:43.211,0:11:47.002 So we looked at this, and we thought, okay, 0:11:47.002,0:11:50.154 artisanal is wonderful in, you know, your clothing 0:11:50.154,0:11:53.098 and your bread and crafts, but 0:11:53.098,0:11:56.081 artisanal really isn't going to work in stem cells, 0:11:56.081,0:11:58.471 so we have to deal with this. 0:11:58.471,0:12:02.391 But even with that, there still was another big hurdle, 0:12:02.391,0:12:05.955 and that actually brings us back to 0:12:05.955,0:12:08.339 the mapping of the human genome, because 0:12:08.339,0:12:11.050 we're all different. 0:12:11.050,0:12:13.882 We know from the sequencing of the human genome 0:12:13.882,0:12:16.439 that it's shown us all of the A's, C's, G's and T's 0:12:16.439,0:12:18.907 that make up our genetic code, 0:12:18.907,0:12:23.176 but that code, by itself, our DNA, 0:12:23.176,0:12:27.775 is like looking at the ones and zeroes of the computer code 0:12:27.775,0:12:30.600 without having a computer that can read it. 0:12:30.600,0:12:33.888 It's like having an app without having a smartphone. 0:12:33.888,0:12:37.772 We needed to have a way of bringing the biology 0:12:37.772,0:12:39.981 to that incredible data, 0:12:39.981,0:12:43.096 and the way to do that was to find 0:12:43.096,0:12:45.783 a stand-in, a biological stand-in, 0:12:45.783,0:12:49.808 that could contain all of the genetic information, 0:12:49.808,0:12:52.336 but have it be arrayed in such a way 0:12:52.336,0:12:55.200 as it could be read together 0:12:55.200,0:12:58.456 and actually create this incredible avatar. 0:12:58.456,0:13:02.160 We need to have stem cells from all the genetic sub-types 0:13:02.160,0:13:05.112 that represent who we are. 0:13:05.112,0:13:07.872 So this is what we've built. 0:13:07.872,0:13:11.192 It's an automated robotic technology. 0:13:11.192,0:13:13.800 It has the capacity to produce thousands and thousands 0:13:13.800,0:13:18.039 of stem cell lines. It's genetically arrayed. 0:13:18.039,0:13:21.788 It has massively parallel processing capability, 0:13:21.788,0:13:25.108 and it's going to change the way drugs are discovered, 0:13:25.108,0:13:28.943 we hope, and I think eventually what's going to happen 0:13:28.943,0:13:31.142 is that we're going to want to re-screen drugs, 0:13:31.142,0:13:33.633 on arrays like this, that already exist, 0:13:33.633,0:13:35.504 all of the drugs that currently exist, 0:13:35.504,0:13:38.415 and in the future, you're going to be taking drugs 0:13:38.415,0:13:41.287 and treatments that have been tested for side effects 0:13:41.287,0:13:43.590 on all of the relevant cells, 0:13:43.590,0:13:46.743 on brain cells and heart cells and liver cells. 0:13:46.743,0:13:50.072 It really has brought us to the threshold 0:13:50.072,0:13:52.286 of personalized medicine. 0:13:52.286,0:13:56.727 It's here now, and in our family, 0:13:56.727,0:13:59.665 my son has type 1 diabetes, 0:13:59.665,0:14:02.313 which is still an incurable disease, 0:14:02.313,0:14:05.755 and I lost my parents to heart disease and cancer, 0:14:05.755,0:14:09.488 but I think that my story probably sounds familiar to you, 0:14:09.488,0:14:13.718 because probably a version of it is your story. 0:14:13.718,0:14:17.662 At some point in our lives, all of us, 0:14:17.662,0:14:20.398 or people we care about, become patients, 0:14:20.398,0:14:23.007 and that's why I think that stem cell research 0:14:23.007,0:14:26.390 is incredibly important for all of us. 0:14:26.390,0:14:30.058 Thank you. (Applause) 0:14:30.058,0:14:37.166 (Applause)